SignalChem Biotech Inc.

We’re thrilled to welcome Dr. Kay-Uwe Wagner to the Cell Signaling Symposium! An internationally recognized leader in oncology, Dr. Wagner has made groundbreaking contributions to breast and pancreatic cancer research. As a professor at Wayne State University and Program Leader at Karmanos Cancer Institute, his work has helped uncover the cellular origins of triple-negative breast cancer. Don't miss out on his lunch session! There's still time to register: https://ow.ly/rKKB50UY6cT #CancerResearch #BreastCancer #Oncology

We’ve added another outstanding speaker to the lineup: Dr. Jason Crawford, Executive Vice President of Drug Discovery at Gandeeva Therapeutics. With expertise in cryo-EM, computational drug discovery, and CMC strategy, Dr. Crawford has played a key role in advancing innovative therapies from bench to bedside. Registration is still open! Save your spot: https://ow.ly/rKKB50UY6cT #CellSignaling #DrugDevelopment #CryoEM #Biotech

We’re excited to announce a new speaker at our Cell Signaling Symposium: Dr. David Vocadlo, University Distinguished Professor of Chemical Biology at Simon Fraser University and CSO of Alectos Therapeutics Inc.! A pioneer in chemical biology and neurodegenerative disease research, Dr. Vocadlo’s work has driven breakthroughs in glycoconjugates and OGA inhibitors, shaping the future of therapeutic development. The symposium is next week! Don't miss your chance to join us in Vancouver on 2/19. Register now: https://ow.ly/ZtBi50UFJlz #CellSignaling #ChemicalBiology #Neurodegeneration #Biotech

Tau proteins play a crucial role in stabilizing microtubules, but when things go wrong, like hyperphosphorylation, these proteins become key drivers of neurodegenerative diseases. From Alzheimer's to epilepsy, researchers are exploring innovative ways to target Tau, including kinase inhibitors, immunotherapies, and nanoparticle-based therapies. This week's newsletter dives into the science behind Tau pathologies and how researchers are leveraging recombinant Tau proteins to advance biomarker discovery and drug development. Curious? Read more here 👇 #Neuroscience #Neurodegeneration #TauProteins #AlzheimersResearch #Biotech

We're excited to announce new speakers for the Cell Signaling Symposium, including Dr. Christian C. Gruber, CEO and co-founder of Innophore! With groundbreaking research in AI-driven enzyme and drug discovery, collaborations with Google and Amazon, and expertise in structural bioinformatics, Dr. Gruber is at the forefront of biotech innovation. His work leverages high-performance computing and the Catalophore approach to advance biomedicine and pharmaceutical research. There's still time to register: https://ow.ly/ZtBi50UFJlz #AI #Biotech #Biomedicine

We’re excited to launch Protein & Antibodies Explained, a video series designed to break down key scientific concepts into quick, digestible insights! We’re kicking things off with "The Destructive Dance of Alzheimer’s Molecules", a look at how Tau proteins & GSK3β contribute to neurodegeneration. #Alzheimers #Protein #Antibodies #Neuroscience

🚨 Win a FREE ticket to our Cell Signaling Symposium! 🚨 We’re raffling off multiple free tickets for our Cell Signaling Symposium on February 19 in Vancouver, Canada! Entering is easy: ✅ Follow our account ✅ Like this post ✅ Fill out the form 👉 https://ow.ly/5rnM50UQusz Winners will be contacted via email. Don’t miss your chance to join top experts and explore the latest in cell signaling research! ⏳ #CellSignaling #ScienceSymposium #Giveaway #LifeSciences

Our headlining keynote speaker, Dr. Xin-Yuan Fu, isn’t just shaping the future of science, he has already changed its course. As the discoverer of the JAK-STAT pathway, Dr. Fu has revolutionized our understanding of mammalian biology, immunity, and disease mechanisms. His work has inspired 100,000+ scientific citations, 12+ FDA-approved drugs, and continues to drive advances in precision medicine through his leadership at GenEros BioPharma. Dr. Fu will take us on a journey through his groundbreaking discoveries and share his vision for the future of science, medicine, and innovation. 👉 Register now for our February 19 symposium: https://ow.ly/ZtBi50UFJlz #JAKSTATPathway #CellSignaling #PrecisionMedicine

We’re excited to introduce one of the keynote speakers for our Cell Signaling Symposium, Dr. Steven Pelech! Dr. Pelech, Professor at the The University of British Columbia and President/CSO of Kinexus Bioinformatics, has over 270 peer-reviewed publications and an illustrious career spanning cell communication systems, cancer, diabetes, and immunology research. He’s also been at the forefront of SARS-CoV-2 antibody monitoring and is a founding member of the Canadian Covid Care Alliance. With decades of expertise and groundbreaking contributions, Dr. Pelech’s keynote promises to inspire and inform! 👉 Secure your spot for February 19: https://ow.ly/ZtBi50UFJlz #KeynoteSpeaker #CellSignaling #Biotech

Spotlight on Dr. Jianyu Li, Associate Professor and Canada Research Chair at McGill University. Dr. Li’s research bridges mechanics, materials, and biomedical engineering, creating biomaterials that advance health technologies and therapies. Recognized as an Innovator under 35 by MIT Technology Review, his work has been featured in NEJM, JAMA, and by BBC and CBC. 📅 Don’t miss Dr. Li at the Cell Signaling Symposium on February 19! 👉 Register now: https://ow.ly/ZtBi50UFJlz #Biomaterials #CellSignaling #Innovation